|
ZNF354B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.11170000041783E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.19809999998832E-06 |
| Normal-vs-Stage2 |
4.53680000001011E-06 |
| Normal-vs-Stage3 |
3.66750000369009E-08 |
| Normal-vs-Stage4 |
2.21539999999409E-05 |
| Stage1-vs-Stage2 |
4.409400E-01 |
| Stage1-vs-Stage3 |
7.032400E-02 |
| Stage1-vs-Stage4 |
7.008400E-01 |
| Stage2-vs-Stage3 |
6.042400E-01 |
| Stage2-vs-Stage4 |
7.590200E-01 |
| Stage3-vs-Stage4 |
3.725600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.99139959867045E-10 |
| Normal-vs-AfricanAmerican |
1.824510E-04 |
| Normal-vs-Asian |
1.155290E-03 |
| Caucasian-vs-AfricanAmerican |
8.790200E-01 |
| Caucasian-vs-Asian |
1.257840E-01 |
| AfricanAmerican-vs-Asian |
3.499800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.45279999977477E-07 |
| Normal-vs-Female |
1.44279999947372E-07 |
| Male-vs-Female |
4.191000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.77169999998817E-06 |
| Normal-vs-Age(41-60Yrs) |
1.16620002543755E-09 |
| Normal-vs-Age(61-80Yrs) |
2.79889999954541E-07 |
| Normal-vs-Age(81-100Yrs) |
2.38519999999909E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.691600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.991400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.735790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.294800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.976600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.135400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.202600E-03 |
| Classical-VS-Follicular |
1.288240E-01 |
| Classical-VS-Other |
7.641800E-01 |
| Classical-VS-Normal |
4.75410000000398E-06 |
| Tall-VS-Follicular |
1.625980E-01 |
| Tall-VS-Other |
6.774100E-02 |
| Tall-VS-Normal |
1.03909999493723E-08 |
| Follicular-VS-Other |
4.686200E-01 |
| Follicular-VS-Normal |
2.07699999976718E-07 |
| Other-VS-Normal |
1.019800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.20710014101167E-10 |
| Normal-vs-N1 |
2.488400E-02 |
| N0-vs-N1 |
2.455700E-02 |
|
|
